Bristol-Myers Squibb Medical Imaging of North Billerica, MA, and Fujisawa Healthcare of Deerfield, IL, have entered into a co-promotion agreement in the U.S. for Fujisawa’s Adenoscan, a pharmacologic stress agent used in myocardial perfusion imaging.
Under the agreement, Bristol-Myers Squibb Medical Imaging will receive a co-promotion fee based on sales of Adenoscan as outlined under the contract, which runs through 2005. Financial details of the agreement were not disclosed.
By AuntMinnie.com staff writersOctober 21, 2003
Related Reading
Definity shows utility for perfusion abnormalities, July 8, 2003
DraxImage, Bristol-Meyers Squibb extend partnership, July 2, 2003
AnorMed, Bristol-Myers Squibb link up, December 10, 2002
Bristol-Myers Squibb appoints imaging chief, July 31, 2002
Bristol-Myers-Squibb, Amersham Health share patent rights, November 15, 2001
Copyright © 2003 AuntMinnie.com
